Cargando…
The impact of COVID-19 vaccination programme in the Republic of San Marino: Focus on effectiveness of Gam-Covid-Vac
OBJECTIVE: The adenovirus-based vaccine Gam-COVID-Vac (Sputnik V) showed promising effectiveness in a phase 3 clinical trial; however, data concerning its impact at a population level are scarce. The Republic of San Marino (RSM) conducted a SARS-CoV-2 vaccination programme mainly based (>80%) on...
Autores principales: | Tonnara, Giuseppe, Piselli, Pierluca, Cimaglia, Claudia, Arlotti, Massimo, Sacchini, Elena, Manoni, Samanta, Zani, Antonio, Muccioli, Fausto, Laderchi, Anna, Rabini, Sergio, Antinori, Andrea, Vaia, Francesco, Nicastri, Emanuele, Girardi, Enrico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251905/ https://www.ncbi.nlm.nih.gov/pubmed/35798146 http://dx.doi.org/10.1016/j.cmi.2022.06.026 |
Ejemplares similares
-
ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance
por: Montalti, Marco, et al.
Publicado: (2021) -
ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance
por: Di Valerio, Zeno, et al.
Publicado: (2022) -
Severe Persistent Eczema in a Recipient of the Gam-COVID-Vac vaccine
por: Ameri, Maryam, et al.
Publicado: (2022) -
Bell's palsy after Sputnik V COVID‐19 (Gam‐COVID‐Vac) vaccination
por: Mirmosayyeb, Omid, et al.
Publicado: (2022) -
Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac)
por: Jeewandara, Chandima, et al.
Publicado: (2022)